scanr
scanr is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at scanr.
scanr is a company.
Key people at scanr.
Scan.com is a healthtech platform that connects patients, clinicians, referrers, imaging centers, and insurers to streamline access to diagnostic imaging like MRIs, CT scans, and ultrasounds.[1][3][6] It solves inefficiencies in booking life-saving scans by offering a single marketplace for comparing costs, locating centers, booking appointments, and accessing educational resources, primarily serving patients and healthcare providers in the UK and US.[1][6] The company has shown strong growth momentum, raising a $12M Series A in 2023 (co-led by Aviva Ventures, YZR Capital, Oxford Capital, Triple Point Ventures, and Simplyhealth Ventures, with Forefront Venture Partners), following a $2M seed in 2021 and $2.2M extension in 2022; it's now a 30-person team expanding into five more US states and developing UK insurer products.[1][3]
Scan.com was founded in 2017 in the UK by clinicians frustrated with diagnostic inefficiencies, who partnered with CEO Charlie Bullock and COO Oliver Knight to bootstrap an automated platform.[1][6] The idea emerged from real-world clinician pain points in organizing scans, leading to a consumer-facing marketplace and API.[1] Early traction came via a 2021 $2M seed round co-led by Oxford Capital and YZR Capital, backed by angels like Tom Blomfield (ex-Monzo) and Evelyn Bourke (ex-BUPA), enabling full-time operations; a 2022 $2.2M extension led by Triple Point Ventures fueled further scaling.[1]
Scan.com rides the healthtech digitization trend, addressing global diagnostic access bottlenecks amid rising demand for faster imaging amid aging populations and chronic diseases.[1][3] Timing aligns with post-pandemic telehealth acceleration and insurer pushes for efficiency, favoring platforms that cut wait times and costs in fragmented markets like the US.[1] It influences the ecosystem by pioneering imaging marketplaces, inspiring fintech-health hybrids (e.g., Aviva/Founders Factory backing), and scaling cross-border to normalize API-driven diagnostics.[3]
Scan.com is poised for US dominance via Series A expansion into new states and payer deals, alongside UK product innovation for insurers.[1] Trends like AI-enhanced imaging and value-based care will amplify its platform, potentially evolving it into a full diagnostics OS with global reach. As healthtech matures, its clinician roots and adaptive model position it to redefine access, building on its trajectory as Europe's fastest grower.
Key people at scanr.
